Biotechnology

Collagen peptide is a structural protein produced by hydrolysis of collagen found in connective tissue, skin, tendons, bones, cartilage, and other body parts. It supports tissues structurally and is involved in cellular functions such as tissue healing, immunological response, cellular communication, and cellular migration. Collagen is generally obtained from bovine connective tissues or marine sources. It has many applications across multiple end-use industries, including food & beverages, pharmaceuticals & nutraceuticals, and personal care. In the food & beverages industry, collagen peptide is used in yogurts, confectioneries, nutritional bars, ready-to-drink beverages, and others. Collagen peptide-induced foods and beverages enhance protein levels in the body; moreover, they help repair skin texture, improve bone and muscle health, and strengthen joints. Rising awareness regarding the health benefits of collagen peptides among customers is driving the demand for collagen...

Stem cells are preliminary body cells from which all other cells with specialized functions are generated. Under a controlled environment in the body or a clinical laboratory, these cells divide to form more cells called daughter cells. Due to the advent of modern health science, these cells play a major role in understanding the occurrence of diseases, the generation of advanced regenerative medicines, and drug discovery. There are certain sources such as embryos, bone marrow, body fats, and umbilical cord blood amongst others, where stem cells are generated. Leading companies operating in the global stem cell therapy market have undertaken various organic and inorganic growth strategies. The global stem cell therapy market comprises MEDIPOST, Pharmicell Co., Inc; RichSource               , BioTime, Inc.; Mesoblast Limited, Holostem Terapie Avanzate Srl; U.S. Stem Cell, Inc; Caladrius Biosciences, Inc.; TiGenix NV, Allo...

Organoids are tiny, self-organized, three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ or to express selected aspects of it, like producing only certain types of cells. Organoids grow from stem cells—cells that can divide indefinitely and produce different types of cells as part of their progeny. Organoids can range in size from less than the width of a hair to five millimeters. Key driving factors include the factors driving organoids market growth are the growing adoption of personalized drugs. Increasing demand for tumor modeling and biobanking. However, issues related to the incorporation of organoids into existing workflows and the dearth of skilled professionals hinder organoids market growth.   The organoids market is majorly comprised of top players involving STEMCELL Technologies Inc; Cellesce Ltd; Hubrecht Organoid Technology; Definigen; Organoid Therapeutics; PeproTech, Inc;...

Organ preservation solutions are used to protect organs prior to transplantation because organs in the outer environment often collapse once removed from the human body. Organ conservation plans are implemented to save and maintain the value of organs for future applications such as transplantation and research. The development of organ preservation technologies is expected to be fueled by growing interest in organ transplantation procedures across the globe. Similarly, developing mechanically propelled techniques for saving organs support the market growth for organ preservation solutions. The Organ Preservation Solution market majorly consists of the players such as Waters Medical Systems LLC, XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST CENTURY MEDICINE, Shanghai Genext Pharmaceutical Technology, Bridge to Life Ltd., Perfusion Solutions, Inc., Lifeline Scientific, to Life Ltd. The companies have ...

Enzymatic DNA synthesis is a well-established technique of DNA synthesis that is useful in synthetic biology, genetic engineering, therapeutic antibodies, vaccine design, and other advanced biological techniques. It is also very helpful to maintain the DNA library and custom DNA synthesis . Major factors driving the market growth include the rising prevalence of genetic disorders and the surging number of product launches. Additionally, growing demand for personalized medicine and DNA data storage is likely to emerge as a significant future trend in the market during the forecast period. The enzymatic DNA synthesis market is comprised of top players involving Telesis Bio Inc; Evonetix; Ansa Biotechnologies, Inc.; Camena Bio; GenScript Biotech Corp.; Molecular Assemblies; DNA Script; Touchlight; Synbio Technologies; and Twist Bioscience; and others. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs...

Biosimilars are safe and effective treatment options for many illnesses such as chronic skin and bowel diseases (like psoriasis, irritable bowel syndrome, Crohn’s disease and colitis), arthritis, kidney conditions, and cancer. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to a FDA ‐ approved biologic product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product. Key driving factors include the Factors driving the biosimilars market growth are the increasing prevalence of chronic diseases and the cost-effectiveness of biosimilar drugs. However, high-cost involvement and complexities in biosimilar product manufacturing hinder the biosimilar market growth.   The biosimilars market is majorly comprised of top players involving Biocon Ltd, Sanofi-Aventis, Celltrion Inc., Amgen Inc., Pfizer Inc., Samsung Bioepis, Sanofi SA, Coherus BioSc...